Economic Issues in the Ovation Complaint
On December 16, 2008, the FTC filed a complaint against Ovation Pharmaceuticals that challenged its 2006 acquisition of the drug Neoprofen from Abbott. (The acquisition had fallen beneath the HSR...
View ArticleDisgorgement and Damages in Ovation
A couple of weeks ago, I posted a blog discussing the FTC’s complaint against Ovation. One of the interesting factors of that complaint was the FTC’s decision to seek disgorgement of profits allegedly...
View Article
More Pages to Explore .....
